JP2024512791A - ニフェジピンとリドカインとを含む局所用ワイプ - Google Patents

ニフェジピンとリドカインとを含む局所用ワイプ Download PDF

Info

Publication number
JP2024512791A
JP2024512791A JP2023561034A JP2023561034A JP2024512791A JP 2024512791 A JP2024512791 A JP 2024512791A JP 2023561034 A JP2023561034 A JP 2023561034A JP 2023561034 A JP2023561034 A JP 2023561034A JP 2024512791 A JP2024512791 A JP 2024512791A
Authority
JP
Japan
Prior art keywords
wipe
topical
concentration
nifedipine
lidocaine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023561034A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024512791A5 (enExample
Inventor
スタール マシュー
シュウェンカー ロビー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Steel Therapeutics Inc
Original Assignee
Steel Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Steel Therapeutics Inc filed Critical Steel Therapeutics Inc
Publication of JP2024512791A publication Critical patent/JP2024512791A/ja
Publication of JP2024512791A5 publication Critical patent/JP2024512791A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2023561034A 2021-04-01 2022-04-01 ニフェジピンとリドカインとを含む局所用ワイプ Pending JP2024512791A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163169768P 2021-04-01 2021-04-01
US63/169,768 2021-04-01
PCT/US2022/023130 WO2022212892A1 (en) 2021-04-01 2022-04-01 Topical wipe containing nifedipine and lidocaine

Publications (2)

Publication Number Publication Date
JP2024512791A true JP2024512791A (ja) 2024-03-19
JP2024512791A5 JP2024512791A5 (enExample) 2025-04-08

Family

ID=83456873

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023561034A Pending JP2024512791A (ja) 2021-04-01 2022-04-01 ニフェジピンとリドカインとを含む局所用ワイプ

Country Status (8)

Country Link
US (1) US20240156756A1 (enExample)
EP (1) EP4312984A4 (enExample)
JP (1) JP2024512791A (enExample)
CN (1) CN117377461A (enExample)
AU (1) AU2022252406A1 (enExample)
CA (1) CA3213764A1 (enExample)
MX (1) MX2023011498A (enExample)
WO (1) WO2022212892A1 (enExample)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04124128A (ja) * 1990-09-13 1992-04-24 Lion Corp 肛門部疾患治療用貼付剤
JP3012732U (ja) * 1994-12-20 1995-06-27 茂郎 槇島 痔治療の薬剤保持部材
JP2001170159A (ja) * 1999-12-19 2001-06-26 Alcare Co Ltd 緩衝能を有する接皮部材
JP2006518711A (ja) * 2003-02-20 2006-08-17 ザ プロクター アンド ギャンブル カンパニー 痔の治療パッド

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8377459B2 (en) * 2003-07-09 2013-02-19 The Procter & Gamble Company Composition for wet wipes that enhances the efficacy of cleansing while being gentle to the skin
WO2014140925A2 (en) * 2013-03-10 2014-09-18 Peritech Pharma Ltd. Topical compositions and methods of treatment of topical disorders
DK3220924T3 (da) * 2014-11-17 2022-01-03 Rev Pharma Corp Lægemiddel til topisk anvendelse til hud- og slimhindeskader i forbindelse med epidermolysis bullosa
WO2016118040A1 (ru) * 2015-01-21 2016-07-28 ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "НоваМедика" Гель, содержащий нифедипин и лидокаина гидрохлорид, его применение и способ приготовления с использованием нанотехнологий
IT201800002413A1 (it) * 2018-02-05 2019-08-05 Carmine Antropoli "composizione a base di nifedipina per uso nel trattamento delle ragadi anali e proctalgie"
WO2020176004A1 (ru) * 2019-02-25 2020-09-03 ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "НоваМедика" Гель для ректального и наружного применения

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04124128A (ja) * 1990-09-13 1992-04-24 Lion Corp 肛門部疾患治療用貼付剤
JP3012732U (ja) * 1994-12-20 1995-06-27 茂郎 槇島 痔治療の薬剤保持部材
JP2001170159A (ja) * 1999-12-19 2001-06-26 Alcare Co Ltd 緩衝能を有する接皮部材
JP2006518711A (ja) * 2003-02-20 2006-08-17 ザ プロクター アンド ギャンブル カンパニー 痔の治療パッド

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DJM, vol. 15(2):98-103, JPN6026004621, 2018, ISSN: 0005795138 *
J MICROENCAPSUL, vol. 34(8):722-731, JPN7026000474, 2017, ISSN: 0005795137 *

Also Published As

Publication number Publication date
CA3213764A1 (en) 2022-10-06
AU2022252406A1 (en) 2023-11-02
EP4312984A4 (en) 2025-02-19
WO2022212892A8 (en) 2023-11-16
EP4312984A1 (en) 2024-02-07
CN117377461A (zh) 2024-01-09
MX2023011498A (es) 2024-01-17
WO2022212892A1 (en) 2022-10-06
US20240156756A1 (en) 2024-05-16

Similar Documents

Publication Publication Date Title
DE69822199T2 (de) Arzneimittel und verfahren zur behandlung von aufmerksamkeitsstörungen und aufmerksamkeits-/hyperaktivitätsstörungen mit methylphenidat
US20140314815A1 (en) Adhesive solid gel-forming formulations for dermal drug delivery
JP5927506B2 (ja) １−メチル−２’，６’−ピペコロキシリダイドの皮膚医薬組成物および使用方法
US20130022564A1 (en) Compositions and methods for dermally treating infections
US20070196452A1 (en) Flux-enabling compositions and methods for dermal delivery of drugs
US20120294907A1 (en) Two or more solidifying agent-containing compositions and methods for dermal delivery of drugs
JP2009519940A (ja) 皮膚科学的状態を処置するための組成物および方法
US20120301517A1 (en) Two or more non-volatile solvent-containing compositions and methods for dermal delivery of drugs
RU2603472C2 (ru) Лекарственная композиция для защиты кожи с комбинацией активных ингредиентов, улучшающей кожный барьер
SK113296A3 (en) Adhesive free topical pharmaceutical formulation
JP2009519958A (ja) 薬物の皮膚送達のための、フラックス化可能な組成物および方法
JP2010531298A (ja) 疼痛を治療するための局所用組成物
EP2032125A2 (en) Ropinirole-containing pharmaceutical compositions in the form of a gel, uses thereof
JP2012126739A (ja) 経皮吸収型製剤
US20070196293A1 (en) Compositions and methods for treating photo damaged skin
JP2009524586A (ja) 疼痛を皮膚処置するための組成物および方法
EP3677265A1 (en) Composition for preventing or treating sleep disorders
JP5667052B2 (ja) ダナゾールを含む経真皮医薬組成物
JP2009519957A (ja) 薬物の皮膚送達のためのスプレイ−オン処方物および方法
JPH09110680A (ja) 皮膚炎治療貼付剤
WO2008012071A2 (en) Pharmaceutical compositions of nicotine and methods of use thereof
JP2024512791A (ja) ニフェジピンとリドカインとを含む局所用ワイプ
JPH11116470A (ja) イデベノン含有経皮投与製剤
Al-Jarsha et al. A review on film forming drug delivery systems
JP7124234B2 (ja) フェノルドパムの安定な局所用組成物

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250331

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250331

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20260116

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20260212